Gynecologic Oncology Handbook An Evidence Based Clinical Guide 3rd Edition by Michelle Benoit, M Yvette Williams Brown, Creighton Edwards – Ebook PDF Instant Download/Delivery: 9780826155979 ,0826155979
Full download Gynecologic Oncology Handbook An Evidence Based Clinical Guide 3rd Edition after payment

Product details:
ISBN 10: 0826155979
ISBN 13: 9780826155979
Author: Michelle Benoit, M Yvette Williams Brown, Creighton Edwards
Known as the “blue book”, the Gynecologic Oncology Handbook: An Evidence-Based Clinical Guide is an invaluable resource for fellows, residents, and clinicians in the diagnosis and management of gynecologic cancers. Retaining the format and features that have made it a leading practical reference, this new edition has been thoroughly updated and reflects the latest advances in surgical techniques, chemotherapy protocols, breakthroughs in immunotherapies and targeted therapies, and much more.
The handbook covers the full scope of disease management in a concise and accessible format. Its compact size allows it to be easily taken with the busy practitioner on the ward or in the clinic. Clear illustrations that reinforce key concepts and essential algorithms for diagnostic techniques help clinicians to a quick and accurate diagnosis. Evidence-based practices for managing gynecologic cancers are emphasized throughout the handbook including for surgical care, and for all adjuvant therapies including chemotherapy, biologics, targeted therapies, immunotherapies, and combination radiation therapy. Detailed sections on survivorship care, palliative care, and management of reproductive function and other comorbid medical conditions round out the book’s comprehensive scope.
Its extensive coverage of current breakthroughs in treatment, references to critical clinical studies, and breakdown of directed gynecologic cancer workups and treatments make the Gynecologic Oncology Handbook, 3rd Edition a go-to resource within the field—including in preparation for the gynecologic oncology subspecialty certification oral board exam.
Key Features:
- Covers all fundamentals of gynecologic oncology including workup, AJCC and FIGO staging, surgical management, chemotherapy, targeted therapy, immunotherapy, and radiation therapy treatment, comorbidity diagnosis and management, and background study data
 - Contains insight into recently approved immunotherapies for recurrent advanced and metastatic cervical and uterine disease
 - Provides Gynecologic Oncology Referral Parameters, Performance Status Scales, Adverse Event Grading, RECIST evaluation criteria, chemotherapy protocols, statistics, and other useful formulas
 - Includes clinical study references, medical comorbidity algorithms, directed workups, and treatment guidelines
 
Gynecologic Oncology Handbook An Evidence Based Clinical Guide 3rd Edition Table of contents:
1. Cancer Screening, Prevention, and Preinvasive Gynecologic Disease
Cervical Cancer Screening
The Human Papilloma Virus
Screening Recommendations
Management Guidelines
HPV Vaccination
Preinvasive Disease
Cervical SILs
AIS
Vulvar SILs
Notable studies
Vaginal Squamous Intraepithelial Neoplasia
SILs and HIV
Uterine Precancer/Endometrial Intraepithelial Neoplasia
Serous Tubal Intraepithelial Carcinoma
Tubo-Ovarian Cancer Screening
Screening Test
CA-125
HE4
Risk of Malignancy Index
Morphology Index
Risk of Ovarian Malignancy Algorithm
Risk of Ovarian Cancer Algorithm
Copenhagen Index
OVA-1 Test
Ovarian Cancer Symptom Index
The UKCTOCS
The PLCO Trial
Japan Screening Study
Serial US of Ovarian Abnormalities
Serial USS for Those With a Family History of OC
GOG 199
Opportunistic Salpingectomy in Low-Risk Women
OC Risk
Changing CA-125 “Normals”
Screening Pelvic Examination in Adult Women
2. Gynecologic Cancers
Cervical Cancer
Characteristics
Pretreatment Workup
Histology
Staging
Treatment Options by Stage
Surgical Treatment
XRT
Adjuvant Posthysterectomy Treatment
Advanced Disease
Recurrent Disease
Survival
Prognostic Factors for Survival
Follow-Up
Neuroendocrine Tumors
Notable Trials in Cervical Cancer
Tubo-Ovarian Cancers: Ovarian, Fallopian Tube, and Primary Peritoneal Cancers
Characteristics
Pretreatment Workup
Treatment
Histology
Staging
Epithelial Tubo-Ovarian Cancer
Histology
Staging
Treatment
Treatment by Stage
Predictive Models for Optimal Surgical Cytoreduction
Genetic Testing
Chemotherapy for Epithelial Tubo-OC
Second Look Laparotomy
Recurrence
Secondary Cytoreduction Surgery
PARP Inhibitors and AML/MDS
Cerebellar Degeneration
Survival
Survival Care
Epithelial TOC Notable Trials
HIPEC/IDS Studies
Low Malignant Potential Ovarian Tumors: Borderline Tumors
Staging
Treatment
Recurrence
Survival
Fallopian Tube Cancer
Histology
Staging
Treatment
Survival
Primary Peritoneal Cancer
Germ Cell Tumors
Staging
Treatment
Recurrence
Follow-Up
Histologic Subtypes and Directed Therapies
GCT Trials
Sex Cord Stromal Tumors
Staging
Treatment
Histology
5YS
Sex Cord Stromal Tumor Trials
Uterine Cancer
Characteristics
Prognostic Factors
Pretreatment Workup
Categorical Divisions
Staging
Treatment
Overview
Recurrence
Fertility-Sparing Options
Postoperative Hormone Replacement Therapy
Synchronous Ovarian Neoplasm
Survival
Follow-Up
Tamoxifen and Uterine Cancer
Notable Studies in Uterine Cancer
Uterine Sarcomas
Leiomyosarcoma
Targeted, Biologic, and Immunotherapies
Notable Studies in Sarcoma
Vulvar Cancer
Characteristics
Histology
Pretreatment Workup
Staging
Treatment
Recurrence
Survival
Follow-Up
Notable Trials
Vaginal Cancer
Characteristics
Pretreatment Workup
Histology
Staging
Treatment
Recurrent Disease
Survival
Follow-Up
Gestational Trophoblastic Disease
Characteristics
Histopathology
Diagnosis
Pretreatment Workup
Serum hCG
Staging
Treatment
Duration of Chemotherapy
Management of Acute Disease and Induced Complications
Resistant Disease
Recurrent Disease
Follow-Up
Notable Trials
3. Hereditary Cancer Syndromes
Hereditary Cancers
Epithelial Ovarian Cancer
Breast Cancer
Heredity Nonpolyposis Colon Cancer/Lynch Syndrome
Li-Fraumeni Syndrome
Cowden Syndrome/PTEN Harmatoma Syndrome (CS/PHTS)
Peutz Jeghers Syndrome
Effectiveness of Screening and Risk-Reduction Recommendations
4. Surgical Care for Gynecologic Cancers
Anatomy
Layers of the Abdomen
Ligaments
Vasculature
Nerves
Vulvar and Groin Anatomy
Lymph Nodes
Potential Spaces in the Pelvis
Preoperative Risk Assessment and Optimization
Recommended Laboratories
Bowel Preparation
American Society of Anesthesiologists Score
Cardiac Risk Score
Functional Status
Frailty Index
Subacute Bacterial Endocarditis
DVT/VTE Prophylaxis
Surgical Bundling
Comorbidity Indices
Surgical Procedures
Laparotomy Incisions
Incision Closure
Lymph Node Dissection
Bowel Diversion
Bowel Resection
Urinary Diversion: Stents, Conduits, and Bladder Reconstructions
Reconstructive Surgery
Splenectomy
Diaphragmatic Stripping
Minimally Invasive Surgery
Surgical Devices
Drains
Central Venous Catheters
Peritoneal Catheters
Catheter Troubleshooting
Instruments
Staplers
Suture
Intraoperative Complications
Vascular Injury
Nerve Injury
GI Injury
Urinary Tract Injury
Intraoperative Hemorrhage
Postoperative Care Protocols
Radical Vulvar Surgery
Radical Hysterectomy
Urinary Conduits and Pelvic Exenteration
Bowel Resection
Ovarian Cancer Debulking
Enhanced Recovery Pathways
Enhanced Recovery After Surgery
Opiates
Postoperative Complications
GI Complications
Hemorrhage
Postoperative Fever
Wound Infection
Urinary Tract Injury
Lymphatic Complications
Nerve Injury
Perioperative Management of Medical Comorbidities
Enhanced Recovery Pathways in Gynecologic Oncology
Vascular Thromboembolism
Nutrition
Endocrine Management
Hepatic Disease
Neurologic Disease
Alcohol Withdrawal
Blood Transfusion
Critical Care
Pulmonary Complications
Cardiac Complications
Shock and Sepsis
Febrile Neutropenia
Renal Complications
Acid–Base Disorders
Electrolyte Abnormalities
Fluids and Blood Products
Electrolytes
Neurologic Care
Risk Stratification of Morbidity and Mortality
5. Gynecologic Cancer Systemic Treatment Modalities
Chemotherapy
One Letter and Combination Chemotherapy Abbreviations
Chemotherapy Definitions
Delivery
Metabolism
Principles of Chemotherapy Tumor Kill
Chemotherapy Regimens
Platinum Sensitivity/Resistance in HGSTOC or Ovarian GCTs
Toxicity
The Cell Cycle
Growth Fraction
Cell Death
Log Kill
Cell-Cycle Nonspecific Chemotherapeutic Agents
Cell-Cycle Specific Agents
Cell Growth
Mechanisms of Cytotoxicity
Mechanisms of Resistance
Prior to Chemotherapy Administration
Classes of Chemotherapeutic Agents and Independent Mechanisms of Action of Alkylating Agents
Antitumor Antibiotics
Antimetabolites
Plant Alkaloids
Hormonal Agents
Novel Drugs
Protective Agents
Antiangiogenesis, Targeted Therapies, and Immunotherapy
Treatment of Extravasation Injury
Neutropenic Fever
Vaccinations in Cancer Patients
XRT
Radiation Types
Definitions
Radiation Effects
Energy Equivalences
Radiation Delivery
Tumoricidal Basics
The Four Rs of Radiation
Disease-Site Radiation Treatment
Design of External Beam Radiation Fields
Radiation Effects
Cervical Cancer and XRT Delivery Time
6. Reproductive Function, Sexuality, and Pregnancy With Gynecologic Cancer
Sexual Function, Fertility, and Cancer
Sexual Dysfunction
Ovarian Protection During Chemotherapy
Fertility Preservation
XRT and Fertility
Cancer in Pregnancy
XRT in Pregnancy
Chemotherapy in Pregnancy
Surgical Management in Pregnancy
Cervical Cancer in Pregnancy
Ovarian Neoplasms in Pregnancy
Other Gynecologic Cancers in Pregnancy
7. Survivorship Care for Gynecologic Malignancies
Surveillance Recommendations
Surveillance Guidelines
Uterine Cancer
Ovarian and Tubal Cancer
Cervical Cancer, Vulvar, and Vaginal Cancer
Melanoma Patients
Survivorship Guidelines
Hormone Replacement
8. Palliative Care
Palliative Care Pathways
Palliative Care
Hospice
End-of-Life Discussion
Multidisciplinary Approach
Communication
Delivering Bad News
Management of Specific Symptoms
Active Dying (Transitioning)
Ethical Issues
Notable Studies
9. Statistics and Reference Material
Statistics
Definitions
Methods Used to Analyze Data
Receiver Operating Characteristic
Endpoints of a Study
Phases of Trials
Randomization Techniques
Eligibility Criteria
Bias and Confounding
Trial Safety, Review, and Ethics
Types of Trials
Trial Evaluation
Survival Analysis
Causality
WHO Screening Guidelines
Parametric Versus Nonparametric Testing
To Quantify Associations
Means of Magnitude
Univariate Versus Multivariate Testing
Surrogate Endpoints
ICER
Reference Material
Surveillance Visit Checklist: Checklist for Surveillance of Gynecologic Malignancies
Gynecologic Oncology Referral Parameters
Performance Status Scales
Adverse Event Grading
Confirmation of Response
Common Chemotherapy Protocols and Dosing
Abbreviations
Index
People also search for Gynecologic Oncology Handbook An Evidence Based Clinical Guide 3rd Edition:
    
gynecologic oncology group surgical procedures manual
    
yale gynecologic oncology
    
gynecologic oncology expert witness
    
women’s gynecologic oncology
    
gynecologic oncology vs gynecology
Tags: Michelle Benoit, M Yvette Williams Brown, Creighton Edwards, Gynecologic Oncology, Clinical Guide


